BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIOA BioAge Labs Inc.

已收盘 09-26 16:00:00 EDT

18.31

+0.31

+1.72%

盘后18.63

+0.32+1.75%

19:58 EDT

最高24.00	最低18.30	成交量462.09万
今开22.50	昨收18.00	日振幅31.67%
总市值6.16亿	流通市值1.92亿	总股本3,367万
成交额9,978万	换手率44.01%	流通股本1,050万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":18.31,"timestamp":1727380800000,"preClose":18,"halted":0,"volume":4620933,"hourTrading":{"tag":"盘后","latestPrice":18.6301,"preClose":18.31,"latestTime":"19:58 EDT","volume":198960,"amount":3739466.8103,"timestamp":1727395120509},"delay":0,"floatShares":10500000,"shares":33667200,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":0.31,"latestTime":"09-26 16:00:00 EDT","open":22.5,"high":24,"low":18.3,"amount":99778549.37522401,"amplitude":0.316667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1727424000000},"adr":0,"listingDate":1727323200000,"adjPreClose":18,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":18.6301,"preClose":18.31,"latestTime":"19:58 EDT","volume":198960,"amount":3739466.8103,"timestamp":1727395120509},"volumeRatio":0},"requestUrl":"/m/hq/s/BIOA","defaultTab":"news","newsList":[{"id":"1174058188","title":"异动解读 | BioAge Labs Inc.(BIOA.US)股价大涨25% 获资本市场看好减肥药研发前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1174058188","media":"异动解读","labels":["movement"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174058188?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:16","pubTimestamp":1727367379,"startTime":"0","endTime":"0","summary":"在纳斯达克交易的生物科技公司BioAge Labs Inc. 股价今日大涨25%,引发了市场的广泛关注。从公司最新消息来看,这与其正在积极筹备的首次公开募股有直接关联。据悉,BioAge Labs计划以每股18美元的价格发行1100万股新股,募集资金高达1.98亿美元。BioAge Labs的主打产品Azelaprag是一种口服小分子药物,已在8个1期临床试验中展现出良好的安全性和耐受性。公司目前正在开展Azelaprag与现有减肥药联合用药的2期临床试验,有望成为全口服肥胖症联合疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | BioAge Labs Inc.(BIOA.US)股价大涨25% 获资本市场看好减肥药研发前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"2470743424","title":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470743424","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470743424?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:56","pubTimestamp":1727405798,"startTime":"0","endTime":"0","summary":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头路透9月26日 - 受经济衰退担忧消退和股市飙升的推动，美国首次公开发行市场在经历了近两年的枯竭期后，于2024年强劲反弹。作为趋势指标的Renaissance IPO指数 .FTIPOUSA，今年迄今为止上涨了约14%。**生技公司大放异彩**Dealogic的数据显示，9月成为今年医疗保健行业IPO最繁忙的月份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240927:nL6T3L9034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKV","BK4185","GRDN","LINE","RDDT","BK4224","BIOA","CON","IPO"],"gpt_icon":0},{"id":"2470971613","title":"生物科技公司BioAge Labs纳斯达克上市：市值6亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2470971613","media":"雷递网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470971613?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:01","pubTimestamp":1727398919,"startTime":"0","endTime":"0","summary":"生物科技初创公司BioAge Labs（股票代码为：“BIOA”）昨日在美国纳斯达克上市，募资总额为1.98亿美元。BioAge Labs开盘价为22.5美元，较发行价上涨25%；收盘价为18.31美元，较发行价上涨1.72%；以收盘价计算，公司市值为6.16亿美元。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.leinews.com/n27839/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["03086","TQQQ","QID","BIOA","BK1147","BK4007","NQmain","PPT","SQQQ","ARTL","MNQmain","PSQ",".IXIC","QLD"],"gpt_icon":1},{"id":"2470918745","title":"敬告客户-以下稿子现予以撤销-美国首次公开募股稳健反弹后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470918745","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470918745?lang=zh_cn&edition=full","pubTime":"2024-09-27 02:41","pubTimestamp":1727376093,"startTime":"0","endTime":"0","summary":"敬告客户-以下稿子现予以撤销-美国首次公开募股稳健反弹后将延续复苏势头STORY_NUMBER: L4T3L81RQSTORY_DATE: 26/09/2024STORY_TIME: 1841 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nL4T3L81RQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKV","BIOA","LINE","BK4185","GRDN","RDDT","BK4547","CON","BK4224","BK4077"],"gpt_icon":0},{"id":"2470573367","title":"图形-美国首次公开募股稳健反弹后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470573367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470573367?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:55","pubTimestamp":1727369747,"startTime":"0","endTime":"0","summary":" Niket  Nishant/Manya Saini    路透9月26日 - 受经济衰退担忧消退和股市飙升的推动，美国首次公开募股市场在经历了近两年的枯竭期后，于 2024 年强劲反弹。以下图表概述了 IPO 市场的现状：强劲上市根据文艺复兴资本公司的数据，今年首次公开募股募集资金至少1亿美元的公司，其交易价格平均上涨约25%，首日涨幅达16%。定位加速 复兴资本公司认为，虽然首次公开募股已从去年的低点回升，但通过此类销售募集的资金远低于10年的历史平均水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","LINE","CON","BK4224","RDDT","BK4185","IPO"],"gpt_icon":0},{"id":"2470541857","title":"更新版 1-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470541857","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470541857?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:23","pubTimestamp":1727367806,"startTime":"0","endTime":"0","summary":"     路透9月26日 - 在投资者热情高涨的背景下，BioAge Labs   周四开盘股价比首次公开发行价高出25%，这家减肥药开发商的首次亮相表现强劲。该公司在纳斯达克的首日开盘价为22.50美元，而首次公开发行价为18美元。根据PitchBook的数据，BioAge首次公开募股的估值为7.575亿美元，相比之下，该公司在2月份的一轮融资 ，融资额为3.943亿美元。BioAge在两次扩大 ，共售出1100万股，比原计划多出46.7%，融资1.98亿美元。 的发行价为市场定价区间 17 美元至 19 美元的中点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2470522927","title":"更新版 2-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470522927","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470522927?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:23","pubTimestamp":1727367806,"startTime":"0","endTime":"0","summary":"更新版 2-投资者押注减肥药热潮，BioAge 首次亮相估值 7.58 亿美元添加第 6 段中的公司背景和分析师评论Arasu Kannagi Basil/Prakhar Srivastava. 路透9月26日 - 周四，在投资者热情高涨的背景下，BioAge Labs BIOA.O的股价较其首次公开发行价高出25%，这家减肥药开发商的首次亮相表现强劲。BioAge在两次扩大 ，共售出1100万股，比原计划多出46.7%，融资1.98亿美元。BioAge 公司称，Azelaprag 与 GLP-1 药物联用一年后，体重有可能减轻 20% 以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240926:nL4S3L81NT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0},{"id":"2470545397","title":"减肥药开发商 BioAge 在纳斯达克首次上市估值 7.58 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470545397","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470545397?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:17","pubTimestamp":1727367423,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月26日 - 周四，BioAge Labs   在纳斯达克首次上市，开盘价比首次公开发行价高出25%，这家减肥药开发商的估值为7.575亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","SQQQ","TQQQ","QID","MNQmain","BK4007","QLD","ARTL","PSQ","NQmain",".IXIC"],"gpt_icon":0},{"id":"2470675101","title":"BIOAGE LABS在纳斯达克上市首日开盘报22.50美元，较18美元的首次公开募股（IPO）价格上涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2470675101","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470675101?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:15","pubTimestamp":1727367324,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["QQQ","159632","SQQQ","BK1147","ARTL","IPO","QLD","BK4007",".IXIC","QID","03086","TQQQ","MNQmain","BIOA","NDX","PSQ","NQmain"],"gpt_icon":0},{"id":"2470813206","title":"减肥药研发公司BioAge Labs(BIOA.US)扩大发行规模至1100万股 IPO定价18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470813206","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470813206?lang=zh_cn&edition=full","pubTime":"2024-09-26 15:59","pubTimestamp":1727337555,"startTime":"0","endTime":"0","summary":"生物科技初创公司BioAge Labs正在筹划通过首次公开发行(IPO)筹集高达1.98亿美元的资金。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20240926/20240926155504_53537.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240926/20240926155504_53537.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1187478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BIOA"],"gpt_icon":0},{"id":"2468083543","title":"生物科技初创公司BioAge Labs(BIOA.US)IPO定价17-19美元/股 拟筹资1.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468083543","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468083543?lang=zh_cn&edition=full","pubTime":"2024-09-19 14:50","pubTimestamp":1726728600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物科技初创公司BioAge Labs于周三公布了其 IPO 条款，该公司计划以 17 至 19 美元的价格区间发行 750 万股股票，筹集 1.35 亿美元。按照提议的范围的中间值，BioAge Labs 的市值将达到 6.02 亿美元。BioAge Labs的主要关注点是代谢疾病，这是全球最大的医疗保健挑战之一。BioAge Labs的主要候选产品 Azelaprag是一种口服小分子，在8个 1 期临床试验中，265 名受试者的耐受性良好。BioAge Labs在2022年、2023年运营亏损分别为3997万美元、4840万美元;净亏损分别为3972万美元、6385万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","BIOA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioAge Labs, Inc.于2015年4月1日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，通过针对人类衰老的生物学特性，开发治疗肥胖等代谢性疾病的候选产品。他们的技术平台和差异化的人类数据集使他们能够根据对驱动衰老的分子变化的见解来识别有前景的靶点。他们的主要关注点是代谢性疾病，这是全球最大的医疗保健挑战之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}